FFA
RLAY icon

Farther Finance Advisors’s Relay Therapeutics RLAY Stock Holding History

Farther Finance Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$75K Buy
4,156
+41
+1% +$785 ﹤0.01% 3087
2026
Q2 		$79.3K Sell
4,115
-186
-4% -$2.7K ﹤0.01% 2896
2026
Q1 		$46.3K Buy
4,301
+161
+4% +$1.44K ﹤0.01% 3044
2025
Q4 		$35K Buy
4,140
+610
+17% +$4.35K ﹤0.01% 3043
2025
Q3 		$18.4K Sell
3,530
-13,172
-79% -$50.2K ﹤0.01% 3103
2025
Q2 		$57.8K Buy
16,702
+16,509
+8,554% +$49.1K ﹤0.01% 2064
2025
Q1 		$478 Sell
193
-2,094
-92% -$8.21K ﹤0.01% 3783
2024
Q4 		$9.42K Buy
2,287
+100
+5% +$544 ﹤0.01% 2409
2024
Q3 		$15.5K Buy
+2,187
New +$16.3K ﹤0.01% 2189
2024
Q2 		– Sell
-25
Closed -$201 – 3908
2024
Q1 		$201 Sell
25
-75
-75% -$732 ﹤0.01% 3275
2023
Q4 		$1.1K Buy
+100
New +$844 ﹤0.01% 2684

Other funds holding RLAY

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's RLAY Position: Q3 2026 in Review

Farther Finance Advisors increased its Relay Therapeutics (RLAY) stake by 1% in Q3 2026, buying an estimated $785 and bringing the position to 4,156 shares worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #3087.

Farther Finance Advisors first reported a position in RLAY in Q4 2023 and has held it in 11 quarters since. The position peaked at $79.3K in Q2 2026. 6 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Farther Finance Advisors held 4,156 shares of Relay Therapeutics worth $75K as of Q3 2026.
  • Farther Finance Advisors bought 41 Relay Therapeutics shares in Q3 2026, an estimated $785.
  • Relay Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3087 holding.
  • Farther Finance Advisors first reported a position in Relay Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Relay Therapeutics position peaked at $79.3K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.